BioHealth News
Pioneering Biotech Advancements: A Conversation with Rachel King, CEO of BIO
Join us for an insightful episode of BioTalk as host Rich Bendis welcomes back Rachel King, the visionary CEO of the Biotechnology Innovation Organization…
Read More
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
GAITHERSBURG, Md., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced NARCAN® Naloxone HCl Nasal Spray 4 mg will be available on shelves nationwide and…
Read More
MedCityNews: Washington D.C.’s Danaher Continues M&A Streak, Buying Life Sciences Firm Abcam for $5.7B
Danaher’s wide-ranging offerings for the life sciences sector will get broader and deeper with the $5.7 billion acquisition of Abcam, a company that makes reagents…
Read More
Lupus Foundation of America and Lupus Canada Award Grant for Study Examining New Method to Predict Treatment Response in Lupus Nephritis to Improve Kidney Outcomes
WASHINGTON, Aug. 28, 2023 /PRNewswire/ -- The Lupus Foundation of America and Lupus Canada are pleased to announce Joan Wither, MD, PhD, FRCPC has been awarded the 2023…
Read More
CellKey, a BHI Partner Company, Emerald Cloud Lab (ECL) Partner to Co-Develop Advanced Glycoprotein Analysis Platform
Los Angeles, CA; September - CellKey, a leading provider of innovative bioanalytical solutions, is thrilled to announce the signing of a Memorandum of Understanding…
Read More
2023 Technology Showcase: A Hub for Biotech Innovation and Collaboration
The Frederick National Laboratory Advanced Technology Research Facility in Frederick, MD, is set to host the 2023 Technology Showcase on September 6, 2023. This…
Read More
TEDCO Announces SSBCI Investment in Polaris Genomics
Maryland-based veteran-owned biotech company is working to transform mental health care COLUMBIA, Md. (August 28, 2023) – Charles Cathlin, CEO of Polaris Genomics (TEDCO…
Read More
The BioHealth Capital Region’s Adaptive Phage Therapeutics lands on Fierce Biotech’s Fierce 15
It’s been a tough year for biotech, so how about a little good news? In between all the layoffs, restructurings and last-ditch strategic option…
Read More
Nurturing Tomorrow’s STEM Leaders: A Conversation With Dr. Judy Staveley, Biotechnologist And STEM Advocate
Explore the world of scientific mentorship and education with Dr. Judy Staveley, an accomplished Chief Biotechnologist and STEM advocate. In this episode of BioTalk,…
Read More
Linshom Medical, Inc. Closes $650K in Series A Round with Investments from Abell Foundation and TEDCO
BALTIMORE, MARYLAND, UNITED STATES, August 15, 2023/EINPresswire.com/ -- Linshom Medical, a Maryland startup medical device company producing innovative advances in respiratory monitoring, received investments of…
Read More
BioHealth Innovation Partners with Big4Bio to Amplify the Voice of the BioHealth Capital Region
Rockville, MD – BioHealth Innovation (BHI), a founding member of the BioHealth Capital Region (BHCR), announces its strategic partnership with Big4Bio, an national aggregator…
Read More
The Johns Hopkins Bloomberg School of Public Health Reaches Next Stage in City Planning Process
The new 250,000-square-foot facility will support the Bloomberg School's mission through dynamic workspaces, state-of-the-art classrooms, and a variety of study, collaboration, and event spaces.…
Read More
Welldoc Receives 11th 510(k) Clearance from FDA for Award-Winning Diabetes Platform BlueStar®
COLUMBIA, Md., August 23, 2023 — Welldoc®, a digital health leader revolutionizing chronic care, today announced the receipt of its 11th 510(k) clearance from the…
Read More
Immunomic Therapeutics Doses First Patient in its Phase 1 Clinical Trial of ITI-1001, a pDNA Vaccine for the Treatment of Glioblastoma Multiforme
ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., a privately held, clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, today announced dosing of the…
Read More
MM+M: Roche, Horizon lead way for pharma reputation among rare disease patient groups
Horizon Therapeutics and Roche rank among the top pharma companies in terms of reputation among rare disease patient groups, according to a recent report…
Read More